TCRT   $0.5162  3.48% Market Closed

Alaunos Therapeutics Inc
Last Events:

2023-07-18 Trend pattern changed from сужающийся канал to нисходящий треугольник.

2023-07-18 Signal in Stochastic changed from bearish to bullish. The stochastic indicator is in overbought territory and it heading south. These factors indicate that perhaps the upside trend is coming to an end. Last signal: signal line crossed the middle level.

2023-07-18 Signal in MACD changed from bullish recovery to bullish reversal. Oscillator MACD is in the negative territory it's higher than the signal line and grows. These factors mean that the falling period is over. Last signal: main and signal line crossing.

2023-07-18 Signal in EMA50 changed from bullish reversal to bearish reversal. 2023-05-26 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-07-18 Trend Power changed from to almost flat.

2023-07-18 Trend changed from flat and down to down and flat.

2023-05-20 Trend pattern changed from восходящий треугольник to сужающийся канал.

2023-05-20 Signal in MACD changed from bullish weakening to bullish recovery. Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: signal line crossed the middle level.


Current temperature: 2.45
ST: 0, Cor:

50-50 Year Forecast
Low with 50% probability: 0.39
Target: 3.50
High with 49% probability: 1.26
Analyst Recommendations:
Number of estimates 5
Target Price Mean 3.50
Mean unverified/preliminary 3.50 / 3.50
Target Price Low / High 1.50 / 7.50
Median / STD DEV 3.00 / 2.37
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell - Sell
rsi Buy ActivelyBuy ActivelyBuy
macd Sell - -
stoch Sell - -
ma20 Sell Sell -
ma50 Sell - -
ma100 Sell - Sell
Candlestick PatternJune 30, 2023 Bullish Three Outside Up - pattern is a made up of three candlesticks. A black candlestick appears on the first day in a downtrend. The second day body engulfs the black body of the first day. A white candlestick on the third day with a higher closethan the second day. Considered to be a bullish reversal pattern.
ISIN US98973P1012
ceo Mr. Dale Curtis Hogue Jr.
Website https://www.alaunos.com
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive T-cell receptor (TCR) engineered T-cell therapies (TCR-T) to treat multiple solid tumor types. It develops Library TCR-T Cell Theraphy, which is in Phase I/II clinical trial for 12 TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian, and bile duct cancers. The company is also developing hunTR, a human neoantigen TCR discovery engine; and Sleeping Beauty Gene Transfer Platform, a non-viral genetic engineering technology. The company was founded in 2003 and is headquartered in Houston, Texas.